A randomized controlled trial of a new intervention in early symptomatic syndromes eliciting neurodevelopmental clinical examinations: PR-ESSENCE

Mats Johnson, Carina Gillberg, Ingrid Vinsa, Gunnar Fransson, Lena Samuelsson, Klara Jakobsson, Sven Östlund, Elisabeth Fernell, Christopher Gillberg, Mats Johnson, Carina Gillberg, Ingrid Vinsa, Gunnar Fransson, Lena Samuelsson, Klara Jakobsson, Sven Östlund, Elisabeth Fernell, Christopher Gillberg

Abstract

The need for effective intervention programs for youth with neurodevelopmental problems (ESSENCE) and challenging behaviour is great. This study examines Problem Resolution in ESSENCE (PR-ESSENCE), a newly developed model in which children and parents develop mutual problem resolution strategies. Ten-week randomized controlled trial of PR-ESSENCE for children and adolescents aged 5-18 years, compared to treatment as usual. Outcomes were assessed at baseline and randomized period endpoint. Primary outcome was the Clinical Global Impression-Improvement scale (CGI-I) rated by blinded assessors. Secondary outcomes were rated by parents-SNAP-IV, Eyberg Child Behavior Inventory (ECBI), Relationship Problems Questionnaire, Family Burden of Illness Module, and children-Beck Youth Inventories (BYI). ClinicalTrials.gov identifier: NCT03780413. The study enrolled 108 participants (active n = 72; controls n = 36, randomized 2:1), of whom 95 completed the randomized period. No clinically significant group differences were found in baseline characteristics. More than half had autism and 80% had ADD or ADHD. Large treatment effects were seen on CGI-I (ITT analysis, Effect Size 1.48). Treatment responders, much/very much improved on CGI-I, were 51.4% in active group and 5.6% of controls. Effect sizes were medium to large in parent ratings on SNAP-IV (ODD and ADHD symptoms), ECBI (behaviour problems), and in BYI child self-ratings of disruptive behaviour. PR-ESSENCE treatment improved global symptoms and functioning (CGI-I), behaviour problems, ADHD and ODD symptoms, and disruptive behaviour. Treatment effects were at least equivalent to those in previous studies of well-established Parent Management Training and Collaborative Problem Solving programs.

Keywords: ADHD; Adolescents; Autism; Children; ESSENCE; PR-ESSENCE.

Conflict of interest statement

MJ has received research grants from Shire and been engaged as a speaker or consultant by Eli Lilly, Shire, Ginsana, PCM Scientific, Evolan, and New Nordic, all unrelated to the present work. All other authors report no conflicts of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
Flow of participants

References

    1. Gillberg C. The ESSENCE in child psychiatry: early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Res Dev Disabil. 2010;31:1543–1551. doi: 10.1016/j.ridd.2010.06.002.
    1. Kadesjö C, Hägglöf B, Kadesjö B, Gillberg C. Attention-deficit-hyperactivity disorder with and without oppositional defiant disorder in 3- to 7-year-old children. Dev Med Child Neurol. 2003;45:693–699. doi: 10.1017/S0012162203001282.
    1. Barkley RA. Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr. 1997;18:271–279. doi: 10.1097/00004703-199708000-00009.
    1. van Stralen J. Emotional dysregulation in children with attention-deficit/hyperactivity disorder. ADHD Atten Deficit Hyp Disord. 2016;8:175–187. doi: 10.1007/s12402-016-0199-0.
    1. Cai RY, Richdale AL, Uljarević M, Dissanayake C, Samson AC. Emotion regulation in autism spectrum disorder: Where we are and where we need to go. Autism Res. 2018;11:962–978. doi: 10.1002/aur.1968.
    1. Greene RW (2010) The explosive child: a new approach for understanding and parenting easily frustrated, “chronically inflexible” children (Revised 4th edition). New York, Harper Collins
    1. Greene RW, Ablon JS, Monuteaux M, Goring J, Henin A, Raezer L, Edwards G, Markey J, Rabbitt S. Effectiveness of Collaborative Problem Solving in affectively dysregulated youth with oppositional defiant disorder: initial findings. J Consult Clin Psychol. 2004;72:1157–1164. doi: 10.1037/0022-006X.72.6.1157.
    1. Ollendick TH, Greene RW, Austin KE, Fraire MG, Halldorsdottir T, Benoit Allen K, Jarrett MA, Lewis KM, Whitmore MJ, Cunningham NR, Noguchi RJP, Canavera K, Wolff JC. Parent management training (PMT) and collaborative & proactive solutions (CPS): a randomized control trial for oppositional youth. J Clin Child Adolesc Psychol. 2016;45:591–604. doi: 10.1080/15374416.2015.1004681.
    1. Johnson M, Östlund S, Fransson G, Landgren M, Nasic S, Kadesjö B, Gillberg C, Fernell E. Attention-deficit/hyperactivity disorder (ADHD) with oppositional defiant disorder (ODD) in Swedish children—an open study of Collaborative Problem Solving. Acta Paediatr. 2012;1:624–630. doi: 10.1111/j.1651-2227.2012.02646.x.
    1. Wechsler D (2003) The Wechsler Intelligence Scale for children. 4th edition. Swedish version. Texas, The Psychological Corporation
    1. Wechsler D (2014) Wechsler Preschool and Primary Scale of Intelligence, 4th edition, WPPSI‐IV. Swedish Version. New York, Pearson Education
    1. Wechsler D (2014) The Wechsler Intelligence Scale for children, 5th edition. Swedish version. New York, Pearson Education
    1. Guy W (1976) ECDEU Assessment manual for psychopharmacology. Revised. Bethesda (MD), US Department of health, education and welfare
    1. Goodman D, Faraone SV, Adler LA, Bryan D, Hamdani M, Weisler R. Interpreting ADHD rating scale scores: linking ADHD rating scale scores and CGI levels in two randomized controlled trials of Lisdexamfetamine Dimesylate in ADHD. Primary Psychiatry. 2010;17(3):44–52.
    1. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40:168–179. doi: 10.1097/00004583-200102000-00011.
    1. Swanson JM, Schuck S, Porter M, et al. Categorical and dimensional definitions and evaluations of symptoms of ADHD: history of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess. 2012;10:51–70.
    1. Eyberg SM, Pincus DB (1999) Eyberg child behavior inventory and Sutter-Eyberg behavior inventory-revised: Professional manual. Odessa, Psychological Assessment Resource
    1. Nixon RD, Sweeney L, Erickson DB, Touyz SW. Parent–child interaction therapy: one- and two-year follow-up of standard and abbreviated treatments for oppositional preschoolers. J Abnorm Child Psychol. 2004;32:263–271. doi: 10.1023/B:JACP.0000026140.60558.05.
    1. Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K. A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD) Curr Med Res Opin. 2007;23:379–394. doi: 10.1185/030079906X167309.
    1. Riley AW, Lyman LM, Spiel G, Döpfner M, Lorenzo MJ, Ralston SJ, ADORE Study Group (2006) The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adolesc Psychiatry (Suppl 1) 15:I/72–I/78
    1. Minnis H, Rabe-Hesketh S, Wolkind S. Development of a brief, clinically relevant, scale for measuring attachment disorders. Int J Methods Psychiatr Res. 2002;11:90–98. doi: 10.1002/mpr.127.
    1. Beck JS, Beck AT, Jolly JB, Steer RA (2005) Beck youth inventories manual: for children and adolescents, 2nd edition. Harcourt Assessment Incorporated
    1. Houck G, Kendall J, Miller A, Morrell P, Wiebe G. Self-concept in children and adolescents with attention deficit hyperactivity disorder. J Pediatr Nurs. 2011;26:239–247. doi: 10.1016/j.pedn.2010.02.004.
    1. Reaven J, Blakeley-Smith A, Culhane-Shelburne K, Hepburn S. Group cognitive behavior therapy for children with high-functioning autism spectrum disorders and anxiety: a randomized trial. J Child Psychol Psychiatry. 2012;53:410–419. doi: 10.1111/j.1469-7610.2011.02486.x.
    1. White SW, Ollendick T, Albano AM, Oswald D, Johnson C, Southam-Gerow MA, Kim I, Scahill L. Randomized controlled trial: multimodal anxiety and social skill intervention for adolescents with autism spectrum disorder. J Autism Dev Disord. 2013;43:382–394. doi: 10.1007/s10803-012-1577-x.
    1. Weston L, Hodgekins J, Langdon PE. Effectiveness of cognitive behavioural therapy with people who have autistic spectrum disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2016;49:41–54. doi: 10.1016/j.cpr.2016.08.001.
    1. Wood JJ, Kendall PC, Wood KS, Kerns CM, Seltzer M, Small BJ, Lewin AB, Storch EA. Cognitive behavioral treatments for anxiety in children with autism spectrum disorder. A randomized clinical trial. JAMA Psychiat. 2019;77:474–483. doi: 10.1001/jamapsychiatry.2019.4160.
    1. Sonuga-Barke EJS, Brandeis D, Cortese S, European ADHD Guidelines Group et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170:275–289. doi: 10.1176/appi.ajp.2012.12070991.
    1. Caye A, Swanson JM, Coghill D, Rohde LA. Treatment strategies for ADHD: an evidence-based guide to select optimal treatment. Mol Psychiatry. 2019;24:390–408. doi: 10.1038/s41380-018-0116-3.

Source: PubMed

Спонсоры и соавторы

Заболевания

Медикаментозные вмешательства

Подписаться